Prognostic value of using FeNO to guide step-down treatment decisions in asthma
<p><strong>Introduction:</strong> Use of fractional exhaled nitric oxide (FeNO) is recommended for asthma diagnosis but its role in guiding safe reduction of inhaled corticosteroids (ICS) is unclear.</p> <p><strong>Aims and objectives:</strong> To assess the...
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Conference item |
| Vydáno: |
European Respiratory Society
2018
|